Clinical Trial Update: A Test of Neural Inertia in Humans With Xenon [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating neural inertia in humans using xenon for neurocognitive dysfunction has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurocognitive Dysfunction

Drugs mentioned

• Xenon (xenon)

Snippet

Sponsor: University of Pennsylvania | Conditions: Neurocognitive Dysfunction | Phase 2 | Status: COMPLETED